Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4825 studies found for:    "Diabetes Mellitus, Type 2"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study
Conditions: Obesity;   Diabetes Mellitus, Type 2;   Abnormal Glucose Metabolism;   Type 2 Diabetes
Intervention: Behavioral: Assignment of a Lay Patient Partner
2 Completed Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: GSK716155 for injection
3 Completed A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone 4 mg
4 Completed Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus;   Diabetes Mellitus, Type 2
Interventions: Drug: GSK189075 oral tablets;   Drug: metformin tablets
5 Completed Study Of AVANDAMET With Or Without Insulin In Type II Diabetes Mellitus Patients
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone/metformin
6 Completed An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: CKD-501 0.5mg;   Drug: Placebo
7 Completed A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: CNTO 3649 IV (Healthy participants);   Drug: CNTO 3649 SC (Healthy participants);   Drug: CNTO 3649 SC (Diabetic patients);   Drug: Placebo
8 Withdrawn A Study in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2608204;   Drug: Glimepiride
9 Active, not recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo
10 Completed Plant-Based Dietary Intervention in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Low-fat, low-Glycemic Index, vegan diet
11 Suspended Plant-Based Dietary Intervention in Type 2 Diabetes-2
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Low-fat, low-Glycemic Index, vegan diet
12 Active, not recruiting Immune Profile and Complication Risk in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention:
13 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
14 Completed Observational Study in Japanese Type 2 Diabetes Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Insulins
15 Terminated Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise
Conditions: Diabetes Mellitus, Type 2;   Overweight
Intervention: Behavioral: Aerobic exercise program - 8 weeks
16 Completed A Study for Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2409021;   Drug: Placebo
17 Completed Exercise Training in Patients With Coronary Heart Disease and Type 2 Diabetes
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2;   Atherosclerosis
Intervention: Behavioral: Exercise
18 Completed Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old
Conditions: Diabetes Mellitus, Type 2;   Insulin Resistance
Intervention:
19 Completed Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: nitroprusside, pentalong, imdur, AICAR, isoptin
20 Active, not recruiting Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Condition: Diabetes Mellitus, Type 2
Interventions: Dietary Supplement: Quercetin;   Drug: Acarbose;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years